Document Detail


Single serum activin a testing to predict ectopic pregnancy.
MedLine Citation:
PMID:  17341564     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
CONTEXT: Ectopic pregnancy (EP) is an important cause of maternal deaths in early pregnancy because most fatal cases result from delayed diagnosis and inappropriate investigation. OBJECTIVE: We evaluated whether the measurement of activin A may be useful in the diagnosis of EP in women with unknown pregnancy location. DESIGN: The study was designed as an open observational study. SETTING: The study was set in a tertiary referral center for obstetric care. PATIENTS: Patients were women with unknown pregnancy location (n = 536) who had complaints of bleeding, pain, or cramping. INTERVENTIONS: Interventions included clinical examination; transvaginal ultrasound scan; human chorionic gonadotropin (hCG), progesterone, and activin A measurements; laparoscopy; uterine curettage; and histological examination. MAIN OUTCOME MEASURES: Main outcome measures were pregnancy outcomes and evaluation of sensitivity, specificity, and predictive values of hCG, progesterone, and activin A as diagnostic tests for the detection of EP. RESULTS: Pregnancy outcomes included 155 (28.9%) viable intrauterine pregnancies (IUP), 305 (56.9%) first-trimester spontaneous abortion (SAB), and 76 (14.2%) EP. SAB had the lowest (P < 0.0001) hCG and progesterone concentrations, significantly lower than EP (P < 0.001) and IUP (P < 0.001). In EP, levels were significantly (P < 0.001) lower than in IUP. On the contrary, activin A levels were lowest (P < 0.0001) in EP, significantly lower than in SAB (P < 0.001) and IUP (P < 0.001). IUP had significantly (P < 0.001) lower activin A levels than SAB. When evaluated by the receiver operating curve analysis, activin A at the cutoff of 0.37 ng/ml combined a sensitivity and a specificity of 100 and 99.6%, respectively, for prediction of EP. When activin A concentrations were below the cutoff, the positive predictive value for EP was 97.43%, and 0% for concentrations higher than 0.37 ng/ml. CONCLUSIONS: Activin A measurement may identify patients at risk of EP with a high sensibility and specificity.
Authors:
Pasquale Florio; Filiberto Maria Severi; Caterina Bocchi; Stefano Luisi; Massimo Mazzini; Secondo Danero; Michela Torricelli; Felice Petraglia
Related Documents :
16169404 - Human chorionic gonadotropin in cervical fluid as a predictor of miscarriage.
1699964 - Serum hcg beta-core fragment is masked by associated macromolecules.
22906914 - Competing risks model in early screening for preeclampsia by biophysical and biochemica...
10831544 - Does icsi affect early serum beta-hcg in pregnancies achieved after ivf?
24670234 - Cervical fluid il-6 and il-8 levels in pregnancies complicated by preterm prelabor rupt...
18722614 - Leisure time physical activity during pregnancy and preterm birth in brazil.
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't     Date:  2007-03-06
Journal Detail:
Title:  The Journal of clinical endocrinology and metabolism     Volume:  92     ISSN:  0021-972X     ISO Abbreviation:  J. Clin. Endocrinol. Metab.     Publication Date:  2007 May 
Date Detail:
Created Date:  2007-05-07     Completed Date:  2007-06-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0375362     Medline TA:  J Clin Endocrinol Metab     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1748-53     Citation Subset:  AIM; IM    
Affiliation:
Chair of Obstetrics and Gynecology, Department of Pediatrics, Obstetrics and Reproductive Medicine, University of Siena, Policlinico Le Scotte, viale Bracci, 53100 Siena, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Activins / blood*
Adult
Chorionic Gonadotropin / blood
Female
Humans
Likelihood Functions
Predictive Value of Tests
Pregnancy
Pregnancy Outcome
Pregnancy, Ectopic / blood*,  diagnosis*
Progesterone / blood
Prospective Studies
ROC Curve
Chemical
Reg. No./Substance:
0/Chorionic Gonadotropin; 0/activin A; 104625-48-1/Activins; 57-83-0/Progesterone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Insulin gene/IDDM2 locus in Japanese type 1 diabetes: contribution of class I alleles and influence ...
Next Document:  Effects of testosterone treatment on endometrial proliferation in postmenopausal women.